SCHEMBL3563594

SCHEMBL3563594

COc1ccc2[nH]c(-c3ccccc3)c(OCCN(C)C)c2c1

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 4/20 0.67
HTR1A P08908 3/20 0.67
HTR1D P28221 3/20 0.67
HTR7 P34969 3/20 0.67
HTR5A P47898 3/20 0.67
SLC6A4 P31645 1/20 0.67
TUBB4A P04350 3/20 0.52
TUBB P07437 3/20 0.52
TUBA3C P0DPH7 3/20 0.52
TUBA1B P68363 3/20 0.52
TUBA4A P68366 3/20 0.52
TUBB4B P68371 3/20 0.52
TUBB3 Q13509 3/20 0.52
TUBB2A Q13885 3/20 0.52
TUBB8 Q3ZCM7 3/20 0.52
TUBA3E Q6PEY2 3/20 0.52
TUBA1A Q71U36 3/20 0.52
TUBA1C Q9BQE3 3/20 0.52
TUBB6 Q9BUF5 3/20 0.52
TUBB2B Q9BVA1 3/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3555901 0.85 HTR2A (0.58) HTR6HTR1AHTR1DHTR7HTR5A
SCHEMBL3565415 0.84 TUBB4A (0.49) HTR6HTR1AHTR1DHTR7HTR5A
SCHEMBL3553981 0.84 PDE10A (0.59) HTR6HTR1AHTR1DHTR7HTR5A
SCHEMBL3555772 0.81 HTR6 (0.64) HTR6HTR1AHTR1DHTR7HTR5A
SCHEMBL5763578 0.81 HTR6 (1.00) HTR6HTR1AHTR1DHTR7HTR5A
SCHEMBL29423321 0.81 HTR6 (1.00) HTR6HTR1AHTR1DHTR7HTR5A
SCHEMBL3555171 0.77 PDE10A (0.50) HTR6HTR1AHTR1DHTR7HTR5A
SCHEMBL855097 0.76 TNKS (0.50) HTR6HTR1AHTR1DHTR7HTR5A
Oxalic Acid SCHEMBL5781188 0.76 HTR6 (0.89) HTR6HTR1AHTR1DHTR7HTR5A
SCHEMBL8856056 0.74 ALOX5 (0.68) HTR6HTR1AHTR1DHTR7HTR5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567492-B1 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LTD (IN) 2013-05-22 EP disclosed
US-7718690-B2 N-arylsulfonyl-3-aminoalkoxyindoles RAMAKRISHNA VENKATA SATYA NIROGI 2010-05-18 US disclosed
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles SUVEN LIFE SCIENCES LIMITED (IN) 2009-05-21 US disclosed
EP-1567492-A2 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES Suven Life Sciences Limited (IN) 2005-08-31 EP disclosed
WO-2004048328-A2 N-ARYLSULFONYL-3-AMINOALKOXYINDOLES SUVEN LIFE SCIENCES LIMITED (IN) 2004-06-10 WO disclosed
WO-2004048331-A1 N-ARYLALKYL-3-AMINOALKOXYINDOLES AND THEIR USE AS 5-HT LIGANDS SUVEN LIFE SCIENCES LIMITED (IN) 2004-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090131507-A1 N-arylsulfonyl-3-aminoalkoxyindoles HTR3C, HTR3A, AANAT HTR6 56/4885HTR1A 20/4885HTR1D 32/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.